Trial Profile
A randomized, double-blind, placebo-controlled study to examine the effect of betahistine on plasma lipids in patients treated with simvastatin
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Betahistine (Primary)
- Indications Lipid metabolism disorders
- Focus Pharmacodynamics
- Sponsors OBEcure
- 07 Jun 2007 Status changed from initiated to recruiting.
- 14 May 2007 New trial record.